Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • reproductive health
Tamoxifen and Uterine Disease Risk in Young Breast Cancer Survivors: Evidence from a Target Trial Emulation Study
Posted inClinical Updates news OB/GYN & Women's Health Oncology

Tamoxifen and Uterine Disease Risk in Young Breast Cancer Survivors: Evidence from a Target Trial Emulation Study

Posted by MedXY By MedXY 03/13/2026
A large-scale cohort study of premenopausal women demonstrates that adjuvant tamoxifen significantly increases the risk of endometrial cancer, hyperplasia, and polyps, with risk correlating to treatment duration.
Read More
Post-Dobbs Abortion Bans Linked to Significant Rise in Postpartum Depression Among Low-Socioeconomic Populations
Posted innews Public Health

Post-Dobbs Abortion Bans Linked to Significant Rise in Postpartum Depression Among Low-Socioeconomic Populations

Posted by MedXY By MedXY 02/06/2026
A retrospective cohort study reveals that state-level abortion bans following the Dobbs decision significantly increased postpartum depression risk by 9% specifically among women in low-socioeconomic communities, highlighting a growing mental health disparity in reproductive healthcare.
Read More
Beyond the Incessant Ovulation Hypothesis: How Menopausal Status and Birth Cohort Reshape Ovarian Cancer Risk
Posted innews Oncology

Beyond the Incessant Ovulation Hypothesis: How Menopausal Status and Birth Cohort Reshape Ovarian Cancer Risk

Posted by MedXY By MedXY 02/06/2026
A massive cohort study of 2.2 million women reveals that ovarian cancer risk factors vary significantly by menopausal status and birth year. While early menarche and low parity remain universal risks, the protective benefits of breastfeeding and oral contraceptives appear specific to premenopausal women.
Read More
Evidence-Based Evolution: How FDA Scientists Shielded Mifepristone Regulation From Political Interference
Posted innews Public Health

Evidence-Based Evolution: How FDA Scientists Shielded Mifepristone Regulation From Political Interference

Posted by MedXY By MedXY 01/17/2026
A comprehensive review of over 5,000 FDA documents confirms that the agency's regulation of mifepristone between 2011 and 2023 was driven by clinical safety data and internal scientific consensus, remaining remarkably resilient against external political pressures.
Read More
Preconception Trace Metal Profiles in Couples: A New Frontier in Optimizing IVF Embryological Outcomes
Posted innews OB/GYN & Women's Health Public Health

Preconception Trace Metal Profiles in Couples: A New Frontier in Optimizing IVF Embryological Outcomes

Posted by MedXY By MedXY 12/27/2025
A prospective study of 1071 couples identifies that plasma trace metal concentrations in both partners significantly influence IVF success, with elements like iron and molybdenum showing benefits while silver and thallium pose risks to embryo quality.
Read More
Undiagnosed Hyperandrogenism in Type 1 Diabetes: Clinical Evidence, Mechanisms, and Screening Implications
Posted inClinical Updates Diabetes & Endocrinology news

Undiagnosed Hyperandrogenism in Type 1 Diabetes: Clinical Evidence, Mechanisms, and Screening Implications

Posted by MedXY By MedXY 12/27/2025
Recent evidence reveals that one in four premenopausal women with Type 1 diabetes (T1D) suffers from undiagnosed androgen excess disorders, primarily the classic PCOS phenotype, necessitating routine screening and a recalibration of reproductive healthcare in diabetic management.
Read More
Benchmarking the Ovarian Reserve: New Population-Based Data Reveal Wide Variability in Young Women
Posted innews Public Health

Benchmarking the Ovarian Reserve: New Population-Based Data Reveal Wide Variability in Young Women

Posted by MedXY By MedXY 12/25/2025
A Norwegian population-based study of 492 women aged 18-22 reveals significant inter-individual variability in ovarian volume, antral follicle count, and AMH levels, providing a critical baseline for understanding reproductive health before the onset of age-related decline.
Read More
Addressing the Silent Crisis: Menstrual Pain and Abnormal Bleeding as Drivers of Acute Care in Sickle Cell Disease
Posted inHematology-Oncology news

Addressing the Silent Crisis: Menstrual Pain and Abnormal Bleeding as Drivers of Acute Care in Sickle Cell Disease

Posted by MedXY By MedXY 12/21/2025
A multicenter study reveals that menstrual pain and abnormal uterine bleeding are highly prevalent in women with sickle cell disease and are linked to increased hospitalizations. Low awareness of hormonal therapies highlights a critical gap in interdisciplinary care and reproductive health management.
Read More
Enhanced Therapeutic Outcomes in Overweight/Obese Women with PCOS: Combining Metformin and Semaglutide
Posted inClinical Updates news OB/GYN & Women's Health Specialties

Enhanced Therapeutic Outcomes in Overweight/Obese Women with PCOS: Combining Metformin and Semaglutide

Posted by MedXY By MedXY 09/16/2025
Combination therapy with metformin and semaglutide improves weight loss, metabolic parameters, menstrual function, and natural pregnancy rates in overweight/obese women with PCOS compared to metformin alone.
Read More
Understanding Reddish-Brown Discharge After Orgasm: Causes and Care
Posted innews OB/GYN & Women's Health Specialties

Understanding Reddish-Brown Discharge After Orgasm: Causes and Care

Posted by MedXY By MedXY 08/07/2025
Explore the physiological and pathological reasons behind reddish-brown discharge after orgasm and learn practical steps for maintaining reproductive health.
Read More
Population Attributable Fractions of Established, Social-Psychological and Reproductive Risk Factors for Stroke Among Women: Evidence from UK Biobank
Posted inClinical Updates Neurology news Specialties

Population Attributable Fractions of Established, Social-Psychological and Reproductive Risk Factors for Stroke Among Women: Evidence from UK Biobank

Posted by MedXY By MedXY 08/07/2025
This study quantifies how established, social-psychological, and reproductive factors contribute to stroke risk in women, highlighting the need for integrated prevention strategies across age groups.
Read More
Decoding Menarche: Its Impact on Long-Term Health
Posted inFamily Medicine & Nutrition Internal Medicine news

Decoding Menarche: Its Impact on Long-Term Health

Posted by MedXY By MedXY 07/29/2025
The age at which a woman experiences her first period could signal potential long-term health risks, including cardiometabolic and reproductive issues. A recent study sheds light on these connections and highlights the need for tailored healthcare strategies.
Read More
  • Beyond a Uniform Approach: Data-Driven Phenotyping Reveals High-Risk Clusters in Gestational Diabetes Mellitus
  • Decoding the Diabetic Heart: Novel Proteomic Signatures of Heart Failure Risk in the ARIC Study
  • Sex-Specific Risk Stratification in Aortic Regurgitation: Moving Beyond One-Size-Fits-All Thresholds
  • Beyond Statins: The Evolution and Clinical Impact of PCSK9 Inhibition in Cardiovascular Risk Management
  • Redefining Heart Valve Disease: The Battle Over Atrial Functional Mitral Regurgitation Guidelines
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular health cardiovascular risk chronic kidney disease clinical trial clinical trials critical care depression diabetes epidemiology exercise health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality nutrition obesity older adults oncology Pediatrics Physical Activity precision medicine Pregnancy prevention prostate cancer public health randomized clinical trial randomized trial SGLT2 inhibitors stroke targeted therapy type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in